Bicisate - 51808-217-01 - (Bicisate)

Alphabetical Index


Drug Information of Bicisate

Product NDC: 51808-217
Proprietary Name: Bicisate
Non Proprietary Name: Bicisate
Active Ingredient(s): 1.35    mg/1 & nbsp;   Bicisate
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Bicisate

Product NDC: 51808-217
Labeler Name: AnazaoHealth Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20120523

Package Information of Bicisate

Package NDC: 51808-217-01
Package Description: 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-217-01)

NDC Information of Bicisate

NDC Code 51808-217-01
Proprietary Name Bicisate
Package Description 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-217-01)
Product NDC 51808-217
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Bicisate
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120523
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name AnazaoHealth Corporation
Substance Name BICISATE
Strength Number 1.35
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of Bicisate


General Information